Table: Wakamoto Pharm - 6-MTH parent results
Nov 7 (Reuters)-
Wakamoto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2022 Sep 30, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4.02 4.01 8.50
(+0.3 pct) (+1.4 pct)
Operating loss 85 mln loss 172 mln 90 mln
Recurring loss 27 mln loss 153 mln 110 mln
(+52.2 pct)
Net loss 21 mln 111 mln 150 mln
(-37.1 pct)
EPS loss 0.62 yen 3.22 yen 4.32 yen
Ann Div NIL
-Q2 div NIL NIL
-Q4 div NIL
NOTE - Wakamoto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T